Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Clinical trial NCT04326036 · UNKNOWN

Trial details

NCT number: NCT04326036
Sponsor: Black Tie Medical, Inc.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pulmonary Alveolar Proteinosis COPD Idiopathic Pulmonary Fibrosis Viral Pneumonia Coronavirus Infection Interstitial Lung Disease

Start date: 2020-03-25
Primary completion: 2023-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.